Clinical Trial Update: Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of intranasal CT001 in children 1-17 undergoing elective surgery, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia

Drugs mentioned

• CT001

Snippet

Sponsor: Cessatech A/S | Conditions: Analgesia | Phase 2 | Status: COMPLETED